CoChat

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

BACKGROUND: New prognostic markers are needed to identify patients with Ewing sarcoma (EWS) and osteosarcoma unlikely to benefit from standard therapy. We describe the incidence and association with outcome of circulating tumour DNA (ctDNA) using next-generation sequencing (NGS) assays. METHODS: A NGS hybrid capture assay and an ultra-low-pass whole-genome sequencing assay were used to detect ctDNA in banked plasma from patients with EWS and osteosarcoma, respectively. Patients were coded as positive or negative for ctDNA and tested for association with clinical features and outcome. RESULTS: The analytic cohort included 94 patients with EWS (82% from initial diagnosis) and 72 patients with primary localised osteosarcoma (100% from initial diagnosis). ctDNA was detectable in 53% and 57% of newly diagnosed patients with EWS and osteosarcoma, respectively. Among patients with newly diagnosed localised EWS, detectable ctDNA was associated with inferior 3-year event-free survival (48.6% vs. 82.1%; p = 0.006) and overall survival (79.8% vs. 92.6%; p = 0.01). In both EWS and osteosarcoma, risk of event and death increased with ctDNA levels. CONCLUSIONS: NGS assays agnostic of primary tumour sequencing results detect ctDNA in half of the plasma samples from patients with newly diagnosed EWS and osteosarcoma. Detectable ctDNA is associated with inferior outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-018-0212-9

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a EFS by ctDNA detection in patients with newly diagnosed localised Ewing sarcoma. b Overall survival by ctDNA detection in patients with newly diagnosed localised Ewing sarcoma
Fig. 1 a EFS by ctDNA detection in patients with newly diagnosed localised Ewing sarcoma. b Overall survival by ctDNA detection in patients with newly diagnosed localised Ewing sarcomaCC BY · PubMed Central
Fig. 2 a EFS by ctDNA detection in patients with newly diagnosed localised osteosarcoma. b Overall survival by ctDNA detection in patients with newly diagnosed localised osteosarcoma
Fig. 2 a EFS by ctDNA detection in patients with newly diagnosed localised osteosarcoma. b Overall survival by ctDNA detection in patients with newly diagnosed localised osteosarcomaCC BY · PubMed Central
Fig. 3 a EFS by 8q gain among patients with newly diagnosed localised osteosarcoma and detectable ctDNA. b Overall survival by 8q gain among patients with newly diagnosed localised osteosarcoma and detectable ctDNA
Fig. 3 a EFS by 8q gain among patients with newly diagnosed localised osteosarcoma and detectable ctDNA. b Overall survival by 8q gain among patients with newly diagnosed localised osteosarcoma and detectable ctDNACC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 149

Metadata

Authors
Shulman, D. S., Klega, K., Imamovic-Tuco, A., Clapp, A., Nag, A., Thorner, A. R., Van Allen, E., Ha, G., Lessnick, S. L., Gorlick, R., Janeway, K. A., Leavey, P. J., Mascarenhas, L., London, W. B., Vo, K. T., Stegmaier, K., Hall, D., Krailo, M. D., Barkauskas, D. A., DuBois, S. G., & Crompton, B. D.
Affiliations
  • Harvard University (US)
  • Dana-Farber Cancer Institute (US)
  • Broad Institute (US)
  • Nationwide Children's Hospital (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • The University of Texas Southwestern Medical Center (US)
  • University of Southern California (US)
  • University of California, San Francisco (US)
  • Children's Oncology Group (US)
Corresponding author
Crompton, Brian D.
Venue
British Journal of Cancer
Published
2018-08
Volume
119
Issue
5
Pages
615-621
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2888384864
Cited by
149
References
38
Citations by year
2026: 21 · 2025: 20 · 2024: 26 · 2023: 25 · 2022: 17 · 2021: 14 · 2020: 14 · 2019: 11 · 2018: 1
FWCI
7.53
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Dr. Ha has a patent pending related to genomic technologies that is not directly related to this work.
  • Dr. Stephen Lessnick holds patents relevant to the diagnosis of Ewing sarcoma
Topics
  • Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords
circulating tumor DNA, Ewing sarcoma, osteosarcoma, prognostic factors, liquid biopsy, event-free survival, overall survival, pediatric bone tumors, hybrid capture sequencing
MeSH terms
Circulating Tumor DNA, Adolescent, Bone Neoplasms, Child, Child, Preschool, Female, Humans, Male, Prognosis, Retrospective Studies, Sarcoma, Ewing, Osteosarcoma, Biomarkers, Tumor, Cohort Studies, Survival Analysis, Sequence Analysis, DNA, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group. https://app.cochat.ai/papers/10.1038/s41416-018-0212-9
The paper
Shulman, D. S., Klega, K., Imamovic-Tuco, A., Clapp, A., Nag, A., Thorner, A. R., Van Allen, E., Ha, G., Lessnick, S. L., Gorlick, R., Janeway, K. A., Leavey, P. J., Mascarenhas, L., London, W. B., Vo, K. T., Stegmaier, K., Hall, D., Krailo, M. D., Barkauskas, D. A., . . . Crompton, B. D. (2018). Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group. British Journal of Cancer. https://doi.org/10.1038/s41416-018-0212-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.